{
  "paper_metadata": {
    "pmid": "17700570",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on two distinct protein-truncating BRCA2 mutations associated with early-onset prostate cancer."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4625_4629delACATT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "Caucasian, diagnosed with prostate cancer before age 55",
        "phenotype": "early-onset prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with Gleason score 7 tumour",
          "evidence_sentence": "One of these mutations was a 5-bp deletion (4625_4629delACATT) and the other was a 2-bp deletion (4074_4075delGT), both located in exon 11."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with Gleason score 7 tumour",
          "evidence_sentence": "One of these mutations was a 5-bp deletion (4625_4629delACATT) and the other was a 2-bp deletion (4074_4075delGT), both located in exon 11."
        }
      ],
      "functional_data": {
        "summary": "Both mutations are protein-truncating and associated with early-onset prostate cancer.",
        "assays": []
      },
      "segregation_data": "Both mutations were detected in Caucasian patients with prostate cancer.",
      "population_frequency": "0.78% (95%CI 0.09\u20132.81%) in Caucasian men",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The estimated cumulative risk of prostate cancer to age 55 years in Caucasian men due to carrying a disease-associated BRCA2 mutation is about 1.1%.",
      "key_quotes": [
        "Results suggest that protein-truncating BRCA2 mutations confer an elevated RR of early-onset prostate cancer.",
        "The estimated cumulative risk (i.e. penetrance) of prostate cancer to age 55 years in Caucasian men due to carrying a disease-associated BRCA2 mutation is about 1.1%."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4074_4075delGT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "Caucasian, diagnosed with prostate cancer before age 55",
        "phenotype": "early-onset prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with Gleason score 7 tumour",
          "evidence_sentence": "One of these mutations was a 5-bp deletion (4625_4629delACATT) and the other was a 2-bp deletion (4074_4075delGT), both located in exon 11."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with Gleason score 7 tumour",
          "evidence_sentence": "One of these mutations was a 5-bp deletion (4625_4629delACATT) and the other was a 2-bp deletion (4074_4075delGT), both located in exon 11."
        }
      ],
      "functional_data": {
        "summary": "Both mutations are protein-truncating and associated with early-onset prostate cancer.",
        "assays": []
      },
      "segregation_data": "Both mutations were detected in Caucasian patients with prostate cancer.",
      "population_frequency": "0.78% (95%CI 0.09\u20132.81%) in Caucasian men",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The estimated cumulative risk of prostate cancer to age 55 years in Caucasian men due to carrying a disease-associated BRCA2 mutation is about 1.1%.",
      "key_quotes": [
        "Results suggest that protein-truncating BRCA2 mutations confer an elevated RR of early-onset prostate cancer.",
        "The estimated cumulative risk (i.e. penetrance) of prostate cancer to age 55 years in Caucasian men due to carrying a disease-associated BRCA2 mutation is about 1.1%."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Characteristics of the two prostate cancer patients with protein-truncating BRCA2 mutations.",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}